MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Functional brain network alterations in the prodromal phase of X-linked dystonia-parkinsonism

J. Steinhardt, C. Diesta, M. Heldmann, J. Dy, J. Tantianpact, H. Hanssen, R. Tuazon, R. Rosales, A. Westenberger, J. Oropilla, N. Brüggemann (Lübeck, Germany)

Meeting: 2023 International Congress

Abstract Number: 1521

Keywords: Disease-modifying strategies, Familial neurodegenerative diseases, Magnetic resonance imaging(MRI)

Category: Neuroimaging (Non-PD)

Objective: To determine whether functional connectivity changes are already present in non-manifesting carriers (NMCs) of the TAF1 gene mutation causing X-linked dystonia-parkinsonism (XDP).

Background: XDP is characterized by rapidly progressive adult-onset dystonia accompanied or followed by parkinsonism over the disease course. At the time of the clinical diagnosis, up to 40% of the striatal volume is already degenerated, indicating a long-lasting prodromal phase without overt clinical symptoms. In NMC, the predicted age at disease onset (AAO) can be calculated by combining effects of different genetic modifiers.

Method: Resting-state functional MRI (rs-fMRI) was performed at 1.5T in 10 male NMCs, 15 XDP patients (XDP), and 25 matched controls negative for the disease-causing mutation (HC). Group-independent component analyses (ICA) were performed using the CONN toolbox. Two movement disorder specialists blinded to the genetic status performed standardized neurological examinations.

Results: We found no differences in motor signs, global cognition, and activities of daily living between NMCs and HCs (all p≥0.579). In NMCs, the predicted time to disease manifestation was on average 9.1 years (SD=7.7). ICA demonstrated decreased connectivity within the default mode network (DMN; FWEc p≤0.01) and increased functional connectivity in the sensorimotor network (SMN; FWEc p≤0.001), including parts of the cerebellum (FWEc p≤0.023) in NMCs when compared to HCs. Decreased functional connectivity within the thalamus and subparts of the cerebellum (FWEc p≤0.01) was found in NMCs compared to XDP patients. In NMCs, the increased cerebellar connectivity correlated with the estimated AAO (FDRcorr p=0.033), whereas functional connectivity alterations within DMN and SMN correlated with time to manifestation (FDRcorr p<0.001).

Conclusion: Rs-fMRI can be used to demonstrate alterations in functional connectivity within cognitive and motor networks in TAF1 NMC. This is in keeping with striatal volume loss that we have recently identified in this group. The relationship with time to the estimated AAO allows more precise predictions for disease trajectories which may be useful for prospective disease-modifying therapies.

To cite this abstract in AMA style:

J. Steinhardt, C. Diesta, M. Heldmann, J. Dy, J. Tantianpact, H. Hanssen, R. Tuazon, R. Rosales, A. Westenberger, J. Oropilla, N. Brüggemann. Functional brain network alterations in the prodromal phase of X-linked dystonia-parkinsonism [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/functional-brain-network-alterations-in-the-prodromal-phase-of-x-linked-dystonia-parkinsonism/. Accessed September 28, 2023.
  • Tweet
  • Email
  • Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/functional-brain-network-alterations-in-the-prodromal-phase-of-x-linked-dystonia-parkinsonism/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Advanced Search
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Welcome to the MDS Abstracts Site
  • Advanced Search
  • #23972 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Patients with Essential Tremor Live Longer than their Relatives
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Insulin dependent diabetes and hand tremor
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2023 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley